MATRIX METALLOPROTEINASES IN SCHWANN CELL NEOPLASIA
施万细胞肿瘤中的基质金属蛋白酶
基本信息
- 批准号:2445857
- 负责人:
- 金额:$ 18.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1996
- 资助国家:美国
- 起止时间:1996-08-19 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION: (Adapted from Applicant's Abstract) Peripheral nerve sheath
tumors are a prevalent feature of neurofibromatosis type 1 (NF1) and Schwann
cells which express relatively high amounts of neurofibromin, appear to be
particularly vulnerable to NF1 gene defects. Schwann cell tumors, including
those in NF1, exhibit graded malignancy and several grades of tumors may
afflict a single NF1 patient. Individual Schwann cell tumors may show loss
of growth control, heightened invasive properties or metastasis. Particular
neoplastic traits are categorically observed in NF1 Schwann cell tumors
whereby benign Schwann cell tumors such as cutaneous neurofibroma exhibit
slow extraneural growth, plexiform neurofibroma retain intraneural
association but may become massive, and neurofibrosarcoma are both highly
invasive and proliferative. Neoplastic traits by cultured Schwann cells
often correlate with expression of matrix metalloproteinases (MMPs). The
present proposal will examine neurofibromin and MMP expression and will
characterize neoplastic traits exhibited by a variety of normal,
tumor-derived, and NF1-mutant Schwann cells. Neoplastic traits include
absence of negative growth control, growth in soft agarose, heightened
invasion of synthetic and natural extracellular matrices, elevated levels of
certain MMPs, and tumor formation in vivo. Additionally, it will be
determined if neurofibromin protein levels are systematically altered in
cultures of NF1 and non-NF1 Schwann cell tumors. Experiments are designed
to test the following hypotheses: a) neoplastic Schwann cells exhibit
altered negative growth involving MMP-3; b) neoplastic Schwann cells have
altered invasion potentials which correspond to expression levels of MMP-1,
MMP-2, and/or MMP-9; c) neurofibromin interacts directly with Schwann cell
tumorigenicity; and d) the severity of neurofibromin-deficiency correlates
with loss of growth control, heightened invasion potential and malignancy.
These studies are designed to test the general hypothesis that Schwann cells
derived from tumors with different grades of malignancy also exhibit
categorically different neoplastic traits in vitro. Also, experiments will
determine if neurofibromin governs individual aspects of Schwann cell
neoplasia. In order to more directly implicate a role for neurofibromin in
Schwann cell neoplasia, we propose the use of NF1 mRNA-and gene targeting
strategies.
描述:(改编自申请人摘要)周围神经鞘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DAVID F MUIR其他文献
DAVID F MUIR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DAVID F MUIR', 18)}}的其他基金
MATRIX METALLOPROTEINASES IN SCHWANN CELL NEOPLASIA
施万细胞肿瘤中的基质金属蛋白酶
- 批准号:
2735681 - 财政年份:1996
- 资助金额:
$ 18.74万 - 项目类别:
MATRIX METALLOPROTEINASES IN SCHWANN CELL NEOPLASIA
施万细胞肿瘤中的基质金属蛋白酶
- 批准号:
2274082 - 财政年份:1996
- 资助金额:
$ 18.74万 - 项目类别:
INHIBITION AND DE-INHIBITION OF NEURITE OUTGROWTH
神经突生长的抑制和去抑制
- 批准号:
2037607 - 财政年份:1992
- 资助金额:
$ 18.74万 - 项目类别:
INHIBITION AND DE-INHIBITION OF NEURITE OUTGROWTH
神经突生长的抑制和去抑制
- 批准号:
2269198 - 财政年份:1992
- 资助金额:
$ 18.74万 - 项目类别:
INHIBITION AND DE-INHIBITION OF NEURITE OUTGROWTH
神经突生长的抑制和去抑制
- 批准号:
2269199 - 财政年份:1992
- 资助金额:
$ 18.74万 - 项目类别:
相似海外基金
Multiplexed enzyme-linked immunosorbent assay workstation for clinical research
用于临床研究的多重酶联免疫吸附测定工作站
- 批准号:
10413539 - 财政年份:2022
- 资助金额:
$ 18.74万 - 项目类别:
Development of an enzyme-linked immunosorbent assay for depression biomarker ethanolamine phosphate
抑郁症生物标志物乙醇胺磷酸酶联免疫吸附测定的开发
- 批准号:
18K05188 - 财政年份:2018
- 资助金额:
$ 18.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Accurate detection of adenylation domain functions in nonribosomal peptide synthetases by an enzyme-linked immunosorbent assay system using active site-directed probes for adenylation domains
使用腺苷酸化结构域活性定点探针,通过酶联免疫吸附测定系统准确检测非核糖体肽合成酶中的腺苷酸化结构域功能
- 批准号:
26750370 - 财政年份:2014
- 资助金额:
$ 18.74万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of a Grb78 enzyme linked immunosorbent assay
Grb78 酶联免疫吸附测定的开发
- 批准号:
453101-2013 - 财政年份:2013
- 资助金额:
$ 18.74万 - 项目类别:
Engage Grants Program
Establishment of domain specific Enzyme-Linked ImmunoSorbent Assay for pemphigus using recombinant proteins expressed by mammalian cells.
使用哺乳动物细胞表达的重组蛋白建立针对天疱疮的域特异性酶联免疫吸附测定。
- 批准号:
25860973 - 财政年份:2013
- 资助金额:
$ 18.74万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Identification of binding media in cultural heritage using ELISA (enzyme-linked immunosorbent assay)
使用 ELISA(酶联免疫吸附测定)鉴定文化遗产中的结合介质
- 批准号:
24700934 - 财政年份:2012
- 资助金额:
$ 18.74万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Development of a Functional Enzyme-linked Immunosorbent Assay
功能性酶联免疫吸附测定的开发
- 批准号:
419162-2011 - 财政年份:2011
- 资助金额:
$ 18.74万 - 项目类别:
Experience Awards (previously Industrial Undergraduate Student Research Awards)
Methods of comparing enzyme linked immunosorbent assay (ELISA) curves
比较酶联免疫吸附测定 (ELISA) 曲线的方法
- 批准号:
347627-2008 - 财政年份:2008
- 资助金额:
$ 18.74万 - 项目类别:
Postgraduate Scholarships - Master's
Methods of comparing enzyme linked immunosorbent assay (ELISA) curves
比较酶联免疫吸附测定 (ELISA) 曲线的方法
- 批准号:
347627-2007 - 财政年份:2007
- 资助金额:
$ 18.74万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's
An Enzyme Linked Immunosorbent Assay (ELISA) for Monitoring Galactosemia
用于监测半乳糖血症的酶联免疫吸附测定 (ELISA)
- 批准号:
7327842 - 财政年份:2007
- 资助金额:
$ 18.74万 - 项目类别: